The firm is seeking marketing clearance for its Liaison NES real-time PCR instrument along with a multiplex test for flu A/B, COVID-19, and respiratory syncytial virus infection.

The guidelines focuse on two weight management medications that have shown superior effectiveness: semaglutide (a GLP-1 receptor agonist) and tirzepatide (a GLP-1/GIP receptor agonist).

DOVER, DE, USA I June 20, 2025 I Lomond Therapeutics Holdings, Inc. (“Lomond Therapeutics”), a clinical-stage biotechnology company dedicated to discovering and developing potentially best-in-class ...

Austin, Texas, United States, June 20th, 2025, FinanceWireHeartBeam (NASDAQ:BEAT) announced it has received FDA 510 (k) clearance for its flagship ECG system, a first-of-its-kind, credit card-sized, ...

LOMOND THERAPEUTICS ANNOUNCES U.S. FDA CLEARANCE OF IND APPLICATION FOR LONITOCLAX, A SELECTIVE BCL2 INHIBITOR WITH LIMITED IMMUNE SUPPRESSION AND IMPROVED SAFETY COMPARED TO VENETOCLAX AND ...

First FDA-cleared smart ring for multi-night sleep testing and 24/7 biometrics — to catch disease early—years before standard care. AUSTIN, Texas, June 19, 2025 /PRNewswire/ -- Happy Health today ...

Cube Click has received approval from the FDA for Smile Dx, its flagship medical device. Smile Dx is an AI-powered diagnostic platform that can identify caries, root canals and periodontal disease at ...

Spine company Expanding Innovations has earned FDA clearance for its N-Gage lumbar plate system. The system is the company’s first spinal-fixation platform, according to a June 18 news release. The ...

VCS Medical manufactures both DentalJect™ (DentalJect.com), the first FDA-cleared direct-application topical anesthetic spray system for oral injections, and CoolJect™ (CoolJect.com), a cold ...

Scienture Holdings, Inc. announced the termination of its Equity Line of Credit facility effective May 22, 2025, as part of a strategic move to focus on the upcoming commercial launch of its FDA ...